key: cord-0781452-u74dkcpz
authors: Acquati, Chiara; Chen, Tzuan A.; Martinez Leal, Isabel; Connors, Shahnjayla K.; Haq, Arooba A.; Rogova, Anastasia; Ramirez, Stephanie; Reitzel, Lorraine R.; McNeill, Lorna H.
title: The Impact of the COVID-19 Pandemic on Cancer Care and Health-Related Quality of Life of Non-Hispanic Black/African American, Hispanic/Latina and Non-Hispanic White Women Diagnosed with Breast Cancer in the U.S.: A Mixed-Methods Study Protocol
date: 2021-12-11
journal: Int J Environ Res Public Health
DOI: 10.3390/ijerph182413084
sha: e6670d378252955d67795572df6cf3e6646a6398
doc_id: 781452
cord_uid: u74dkcpz

The COVID-19 pandemic has had critical consequences for cancer care delivery, including altered treatment protocols and delayed services that may affect patients’ quality of life and long-term survival. Breast cancer patients from minoritized racial and ethnic groups already experience worse outcomes, which may have been exacerbated by treatment delays and social determinants of health (SDoH). This protocol details a mixed-methods study aimed at comparing cancer care disruption among a diverse sample of women (non-Hispanic White, non-Hispanic Black/African American, and Hispanic/Latina) and assessing how proximal, intermediate, and distal SDoH differentially contribute to care continuity and health-related quality of life. An embedded mixed-methods design will be implemented. Eligible participants will complete an online survey, followed by a semi-structured interview (with a subset of participants) to further understand factors that influence continuity of care, treatment decision-making, and self-reported engagement. The study will identify potentially modifiable factors to inform future models of care delivery and improve care transitions. These data will provide the necessary evidence to inform whether a subsequent, multilevel intervention is warranted to improve quality of care delivery in the COVID-19 aftermath. Additionally, results can be used to identify ways to leverage existing social resources to help manage and support patients’ outcomes.

The outbreak of Coronavirus Disease 2019 (COVID-19) has affected 230 million people worldwide, with 42 million cases registered in the USA and approximately 688,000 deaths 2 of 16 as of summer 2021 [1, 2] . COVID-19 disproportionately burdens minoritized racial and ethnic minorities [3] , such as Black/African American and Hispanic/Latinx adults who have higher rates of COVID-19 infection than their non-Hispanic White (NHW) counterparts [3] [4] [5] [6] . These minority groups are also overrepresented among hospitalized patients with the disease [7] and face proportionally higher mortality rates [4, 8, 9] . This is at least partially attributable to the exacerbation of pre-existing racial and health inequalities associated with social determinants of health (SDoH) [10] [11] [12] , and rising rates of unemployment and loss of medical insurance [13] [14] [15] that have a greater effect on minority groups' financial resources [16] [17] [18] . These same groups have lower incomes and higher proportions of poverty [19] , public insurance or being uninsured [20, 21] compared to NHWs.

Racial and ethnic minority groups share the unequal burden of being more likely to be low-income essential workers [22] and unemployed [23, 24] , forcing these populations to make economic cutbacks during the pandemic [22] , which induces elevated stress and anxiety [22] . Residential racial segregation has been also consistently linked with a variety of adverse health outcomes, underlying health conditions, and affects minoritized groups more than NHWs [25] [26] [27] . Access to health services is contingent upon insurance and user-pay systems, which may disproportionately negatively affect those from minority groups [28] . Additionally, these groups may not have the health literacy skills necessary to fully respond to pandemic messaging [29] or to evaluate true versus misinformation on the virus. Consequently, racial and ethnic minority groups are likely to experience reduced life expectancies that are three to four times larger than in NHWs during the COVID-19 pandemic [30] . In sum, COVID-19 disparities in incidence and mortality should be situated in the context of multiple factors that affect health-related outcomes, such as material resources deprivation, access to social networks, and chronic stress due to structural discrimination [12] .

Cancer patients have an increased risk of contracting COVID-19 [7, 31] , being hospitalized [7, 31] , and succumbing to the virus [32] . This vulnerability is due to being immunocompromised as a result of the malignancy itself and systemic anticancer therapies, resulting in higher susceptibility to severe infections and complications [32] [33] [34] [35] [36] . Thus, their long-term survival may be particularly affected by delays in surgery and administration of anticancer therapies [33] [34] [35] [36] . Breast cancer patients in active treatments, compared to other groups, are the most likely to be infected with COVID-19 [7] . Notably, Black/African American breast cancer survivors are more likely to be diagnosed with COVID-19 compared to their NHW counterparts; the largest racial disparity for infection compared to other cancers [7] .

The pandemic has had critical consequences for cancer care delivery [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] including a reduction in cancer screenings [47] , diagnoses [47, 48] , and surgeries [47] . Recommendations and guidelines for triage, prioritization and altered treatment regimens [49] [50] [51] [52] [53] [54] have also contributed to modifications to care protocols and the transition to tele-medicine services [8, 13, [35] [36] [37] [38] [39] [40] [41] 47, 48] . However, this adaptation of treatment pathways can have long-term implications for the timely detection of disease progression and complications that may affect cancer outcomes [13, 39, 40, 55] . In May 2020, 79% of cancer patients in active treatment experienced some delay in their health care because of COVID-19 [56] ; which may affect long-term survival because of suboptimal or delayed care [8, 13, [39] [40] [41] 55, [57] [58] [59] . Together, these trends can exacerbate pre-existing disparities in cancer morbidity and mortality experiences by Black/African American and Hispanic/Latinx adults [47, [60] [61] [62] .

In terms of breast cancer care, the pandemic has led to reductions in screening/diagnostic mammography [47, 63, 64] , diagnoses [47, 48, 65] , surgeries [47, 66] including breast reconstruction [66, 67] and genetic counseling/testing [63, 64] . The reduction in the number of biopsies (71%) and diagnoses (51.8%) is higher in breast cancer compared to other cancers [47, 48] . Additionally, registered breast cancer treatment delays [64, 65, [68] [69] [70] [71] [72] , may be due to fear of COVID-19 infections [66, [69] [70] [71] [72] [73] . Disruptions to oncology services nega-tively impact emotional well-being, anxiety and depression experienced by breast cancer patients, which have been associated with greater emotional vulnerability and poor cognitive function [68, 69] . Breast cancer patients from racial and ethnic minority groups already experience significantly more cancer treatment delay [74] [75] [76] [77] [78] , which may exacerbate COVID-19 related treatment delays and psychosocial outcomes in these groups [68, 77] The disproportionate burden of breast cancer is well documented, with Black/African American and Hispanic/Latina women reporting worse health outcomes than their NHW counterpart [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] . For instance, in Texas, where breast cancer is the leading cancer diagnosis, mortality is 44% higher for Black/African American than NHW women [79, 91] . Disparities exist in incidence, mortality, and importantly, survivorship care [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] . Traditional explanations have included biologic differences in tumor characteristics [81] , late-stage diagnosis due to lack of cancer screening [91] [92] [93] , and socioeconomic factors [83, 94] . However, a growing body of literature suggests that differences in selection and adherence to recommended treatments may play a major role in the maintenance of disparities in breast cancer outcomes [83, [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] . In the current oncologic practice, where timely engagement with treatment is crucial to prevent recurrence and reduce mortality [89, 90] , differences in treatment initiation and adherence to treatment have become increasingly relevant given the present recommendations for triage and modified delivery of cancer care [75, [95] [96] [97] [98] [99] . Black/African American women are four times more likely to experience treatment delays and less likely to receive cancer-directed surgery; additionally, Black/African American and Hispanic/Latina women also fail to receive definitive local therapy, chemotherapy, and radiotherapy [99] [100] [101] . Minority breast cancer patients are disproportionally characterized by non-initiation, discontinuation, and non-adherence to adjuvant endocrine therapy [98] [99] [100] [101] [102] [103] [104] , which leads to lower survival, shorter time to recurrence, increased medical costs, and lower quality of life [87, [98] [99] [100] [101] [102] [103] [104] [105] . Key determinants of disparities range from proximal factors (socio-demographic variables), to intermediate (social network characteristics), and distal factors (access to resources; healthcare system characteristics, and policy) [88] [89] [90] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] . Although multiple levels of contextual influences affect behavior, currently available interventions to alleviate breast cancer disparities fail to comprehensively address these SDoH, or the interplay between them [106] . For minoritized racial and ethnic women receiving treatment for breast cancer, the effects of SDoH coupled with COVID-19 altered treatment protocols [54, [110] [111] [112] may exacerbate the existing disproportionate burden of the disease [80] [81] [82] [83] 95, 105, 106] . More research is therefore needed to understand these potential effects and how to address them to achieve breast cancer health equity.

The present paper describes an NCI-funded mixed-methods study protocol investigating the impact the COVID-19 pandemic has on the receipt of optimal breast cancer care among a diverse sample of women (non-Hispanic Black/African American, Hispanic/Latina, and NHW). For the purpose of this investigation, groups were defined according to the classification from the U.S. Office of Management and Budget (OMB), which is used for the 2020 Census categorization of race and ethnicity. Individuals who identify with the ethnicity of Hispanic/Latinx may be of any race. This research project will fill a significant gap in current understanding of the long-term implications of the pandemic on cancer disparities by assessing differential rates of cancer care disruption and health-related quality of life among non-Hispanic Black/African American and Hispanic/Latina women (relative to non-Hispanic White women) diagnosed with early-stage breast cancer. The study will also examine how proximal, intermediate, and distal SDoH differentially contribute to these outcomes to inform future interventions able to sustain equitable models of care delivery.

The study utilizes an embedded mixed methods design [113] , chosen for the purpose of complementarity, in which the addition of qualitative data is used to enhance or elaborate upon the results of quantitative analyses. Each component will be used to capture overlapping, but distinct aspects of participants' experiences [113] , i.e., quantitative data will include psychosocial outcome measures, while qualitative data will focus on capturing the context of care such as women's personal experiences of barriers and processes in accessing care. In this embedded design, quantitative and qualitative data will be collected concurrently, in which the second qualitative strand builds on the first quantitative strand and the qualitative interview participants are selected from among the survey respondents, integrating strands on the methods level through connection via the sampling frame [114] . Integration will also occur during the interpretation and reporting stages where the analyses from the two strands are integrated and compared through use of a joint display table. Integration will be achieved through using qualitative findings to elaborate or enhance upon quantitative results, yielding a more comprehensive view of participants' experiences and barriers to care.

Study procedures will occur in two virtual "visits". In the first visit, eligible patients complete an online survey assessing proximal, intermediate, and distal factors affecting care continuity and quality of life. In the second visit, a semi-structured interview is conducted with a selection of self-referred women to assess factors that influenced their access to and continuity of care.

Funding for the current protocol was obtained from the National Cancer Institute of the National Institute of Health (3P20CA221697-04S1), supported by grants P20CA221696 (to Lorna H. McNeill) and P20CA221697 (to Lorraine R. Reitzel).

The conceptual framework of the study is based on the National Institute on Minority Health and Health Disparities (NIMHD) Research Framework [115, 116] and the Centers for Population Health and Health Disparities (CPHHDs) [117, 118] multilevel model, which are grounded in socio-ecological theory [119] . As outlined in Figure 1 , the study targets (1) proximal, (2) intermediate, and (3) distal determinants of health disparities to identify which of them differentially influences cancer care receipt, patient-reported outcomes, and the interplay between them. Distal determinants include policies and organization/practice settings that affect the availability, receipt of, and quality of health care [115, 117] . Intermediate determinants include social context, physical environment, and social relationships [115, 117, 120, 121] . Social relationships refer to social networks, which are forms of social capital that suppress the negative effects of impoverished social environments. These negative effects can, in the absence of such networks, be increased by social isolation [122] [123] [124] [125] [126] [127] [128] . The physical environment includes availability and accessibility of local health care resources; transportation, quality air and water, healthy food; presence of crime; and neighborhood characteristics [129, 130] . Finally, proximal determinants are embedded in the individual and include socioeconomic status, race/ethnicity, gender identity, and cultural beliefs; they also include engagement in risk behaviors [115, 116, 118 ]. The conceptual model of the study is informed by the taxonomy proposed by Taplin and Rodgers [131] about factors influencing the quality of cancer care and ultimately cancer-related health outcomes. This model also integrates recent evidence-based recommendations for the development of multilevel interventions to address racial/ethnic disparities [132] [133] [134] .

recommendations for the development of multilevel interventions to address racial/ethn disparities [132] [133] [134] . 

Specific aims are to: 1. Identify and compare rates of disruption in cancer care due to the COVIDpandemic and health-related quality of life among non-Hispanic Black/Afric American, Hispanic/Latina, and non-Hispanic White women diagnosed w early-stage breast cancer.

predict cancer patients' disruption of care and health-related quality of life du ing and after the acute phase of COVID-19 pandemic. 3. Identify barriers and facilitators of cancer care receipt and health-related qual of life among participants who report high vs. low rates of cancer care disru tions during the COVID-19 pandemic. It was hypothesized that: (1) differences in cancer care disruption and health-relat quality of life will exist among non-Hispanic Black/African American, Hispanic/Lati and non-Hispanic White women diagnosed with early-stage breast cancer; and that higher rates of disruptions and more affected health-related quality of life will be expe enced by participants who identify as non-Hispanic Black/African American or H panic/Latina, those with lower socioeconomic status, no insurance, and those reporti greater distress and more negative coping approaches. In addition, it was hypothesiz that (3) higher rates of disruptions and more affected quality of life will be experienced participants with lower social support and reduced social network size. Finally, (4) wo outcomes were expected to be reported by participants receiving care in institutions lac ing patient navigation and psychoeducation, access to tele-medicine services, and limit community level resources.

Community-engaged approaches to survey development and recruitment strateg guide the research project. The investigative team presented the study materials (flye scripts and survey instruments) to a local Community Research Advisory Board (s https://www.healthrcmi.com/crab, accessed on 29 November 2021) and an External Ad sory Board (see: https://www.uhandpartnership.com/external-advisory-board, access on 29 November 2021), eliciting community-scientists feedback and making modificatio accordingly. Participants will be recruited through a variety of strategies to maximize t likelihood of reaching the expected sample size, placing particular emphasis on equal re resentation among the three groups. Breast cancer survivors will be recruited from lo and national community-based organizations and advocacy groups for women's hea It was hypothesized that: (1) differences in cancer care disruption and health-related quality of life will exist among non-Hispanic Black/African American, Hispanic/Latina, and non-Hispanic White women diagnosed with early-stage breast cancer; and that (2) higher rates of disruptions and more affected health-related quality of life will be experienced by participants who identify as non-Hispanic Black/African American or Hispanic/Latina, those with lower socioeconomic status, no insurance, and those reporting greater distress and more negative coping approaches. In addition, it was hypothesized that (3) higher rates of disruptions and more affected quality of life will be experienced by participants with lower social support and reduced social network size. Finally, (4) worse outcomes were expected to be reported by participants receiving care in institutions lacking patient navigation and psychoeducation, access to tele-medicine services, and limited community level resources.

Community-engaged approaches to survey development and recruitment strategies guide the research project. The investigative team presented the study materials (flyers, scripts and survey instruments) to a local Community Research Advisory Board (see: https: //www.healthrcmi.com/crab, accessed on 29 November 2021) and an External Advisory Board (see: https://www.uhandpartnership.com/external-advisory-board, accessed on 29 November 2021), eliciting community-scientists feedback and making modifications accordingly. Participants will be recruited through a variety of strategies to maximize the likelihood of reaching the expected sample size, placing particular emphasis on equal representation among the three groups. Breast cancer survivors will be recruited from local and national community-based organizations and advocacy groups for women's health and breast cancer prevention, in collaboration with patient advocates and community health workers. In addition, recruitment scripts and flyers will be disseminated via social media, during breast cancer-related community events, and through postings on community bulletin boards in Black/Latinx communities and churches. Study recruitment efforts will be conducted also in target clinic-sites serving women with breast cancer from minority groups, including targeted emails to participants of previous studies who have expressed interest in being contacted for future research.

The target sample will comprise 120 breast cancer patients equally divided in groups of 40 non-Hispanic Black/African American, 40 Hispanic/Latina and 40 NHW women. Additionally, purposive sampling will be used to select a subset of 30 women, stratified by race/ethnicity and low vs. high rates of disruption in care, to complete an individual semi-structured interview to further understand factors influencing continuity of care and treatment decision-making. Initially, women will be selected for interviews on a first-come, first-served basis, with attention to ensuring equal representation by race/ethnicity until n = 30 is reached. Once data analysis has commenced, theoretical sampling will also guide selection of interviewees in keeping with grounded theory.

Inclusion criteria for the present study are:

1.

Self-identify as non-Hispanic Black/African American, Hispanic/Latina, or NHW woman; 2.

Having been diagnosed with early stage (I-III) breast cancer in January 2020 or later; 3.

Receiving care for breast cancer at time of enrollment; 4.

Being 18 years of age or older; 5.

Having access to a computer, smartphone, tablet, or other devices allowing the capability to complete internet-based survey and interview; 6.

Having the ability to speak and read English.

The exclusion criteria are:

1. Having a cognitive impairment or severe mental illness; 2.

Being unable to consent; 3.

Being in prison/custody; or 4.

Being diagnosed with metastatic disease.

Potential participants are presented with a list of exclusionary criteria and asked to select out of the study if any inclusion criteria are not met or if any exclusion criteria are applicable.

Demographic/medical characteristics: Participants will be asked sociodemographic information including age, sex at birth, gender identity, race/ethnicity, marital status, duration of current relationship (if applicable), religious affiliation, number of children, occupational status, education, insurance status, income, and residential street address. Medical information will include cancer diagnosis (first diagnosis vs. recurrence), stage of the disease, time since diagnosis, and treatment type.

Proximal determinants: Psychological distress is assessed with the Perceived Stress Scale [135, 136] , consisting of 10 items that examine the degree to which situations in one's life are appraised as stressful. Coping is measured with the Brief COPE [137] , a multidimensional measure assessing 14 coping dimensions. The Brief COPE has been shown to be reliable, valid, and it has been extensively used with breast cancer patients [138] [139] [140] [141] . The Cancer Behavior Inventory-Brief Version (CBI-B) [142] , assesses respondents' selfefficacy in managing the illness. Health literacy is measured with the single health literacy screening measure [143] . Individual risk factors such as smoking, alcohol and substance use, physical activity, and diet (cups of fruits and vegetables consumed) will be assessed with single items [144] . Depression and anxiety will be assessed with the Patient Health Questionnaire-8 [145] [146] [147] and the GAD-7 [148] .

Intermediate determinants: Social support will be measured with the MOS Social Support Scale [149] , a 19-item questionnaire assessing tangible, emotional/informational, affectionate support, and positive social interaction. The PROMIS Social Isolation Scale [150] [151] [152] , 4 items, will assess social isolation. In addition, the Social Network Index (12 items) [153] will examine characteristics of the social network of the individual. Emotional intimacy with a partner will be measured with six items from the Personal Assessment of Intimacy in Relationships (PAIR) Inventory [154] . Local community level resources and characteristics will be examined through GIS data based on geocoding each participant's residential address [155] . Participants also complete two five-item brief measures of Social Cohesion and Trust and Informal Social Control [156] , as well as a 10-item measure of Neighborhood Problems [157] .

Distal determinants: Participants will complete questions, developed by the investigators, about the healthcare setting where they have been receiving care and will be invited to report whether patient navigation, education and supportive services are offered, and whether these services have transitioned to telehealth because of the pandemic. Additionally, women's experience with health care services and medical mistrust will be investigated with Short-Form Patient Satisfaction Questionnaire (PSQ-18) [158] , and the Group-Based Medical Mistrust Scale [159] , a 12-item instrument designed to assess race-based medical mistrust from health care systems/professionals and the treatment provided to individuals of the patient's ethnic or racial group.

Disruption in Cancer Care: Cancer care disruptions will be measured with a series of questions investigating the impact of the COVID-19 outbreak on access to health care services (such as the type of health care services that have been impacted and the reason for the change in care). Questions have been adapted from the ACS CAN COVID-19 Impact on Cancer Patients and Survivors survey with permission [160] .

Health-Related Quality of Life: Health-related quality of life will be assessed with the Functional Assessment of Cancer Therapy-Breast (FACT-B) Scale [161] , a 37-item instrument measuring physical, social/family, emotional, and functional well-being, along with breast cancer-specific concerns. In addition, four items from the Behavioral Risk Factor Surveillance System survey [162] have been included. Items assess (a) self-rated health, (b) poor physical health days, (c) poor mental health days, and (d) activity limited days due to poor physical or mental health. Self-rated health is assessed with a single item with which participants rate their health on a 5-point scale from excellent (1) to poor (5) . Finally, participants will be invited to report the number of days in the previous 30 days in which poor physical or mental health limited their ability to perform usual activities [162] .

At the end of the online survey, participants will be invited to express their interest in participating in a qualitative interview (n = 30). The goal of the interview is to assess factors that influence women's access to and continuity of care, treatment decision-making, self-reported engagement in the process of care, and overall satisfaction. A semi-structured topic guide will be used to focus interviews; however, it will remain open and flexible to change to respond to participants' experiences and concerns. In addition, women will be asked about how their social networks facilitated or impaired their cancer treatment management. Those who express interest will be contacted by the research team via e-mail/phone. Members of the research team will share information about the topics covered in the interviews, how interviews will be conducted and how data will be collected. Participants will be orally consented at the beginning of the interview. Instructions will be provided to participants to access the HIPAA-compliant online platform selected for the interview. Online interviews were chosen to reduce the risk of exposure to COVID-19.

Power and sample size requirements were based on (1) Aim 1: one-way analysis of variance (ANOVA) with one between subjects factor (i.e., three racial/ethnic groups), and (2) Aim 2: regression analyses with maximum of eight predictors when examining the effect of differential factors (e.g., proximal, intermediate, distal, and their sub measures). Power analysis showed that there is 80% power to detect a moderate (0.25) to large (0.40) effect size of 0.287 (f) for Aim 1 and 0.067 (f 2 ) for Aim 2 [163] . Given one between subjects factor design (Aim 1) and regression analyses (Aim 2), two-sided significant level, an alpha of 0.05, and 120 participants (40 participant in each racial/ethnic group). Additionally, with the sample size of 120, it will be possible to detect as small as w of 0.28 for chi-square tests, and correlation of |r| of 0.25 or larger when assessing the correlation between two continuous variables.

Descriptive analyses will be computed to characterize the distributional nature of all variables. ANCOVAs controlling for covariates (e.g., age) will explore mean differences between racial/ethnic groups, whereas chi-square tests will compare participants and those who withdrew on sociodemographic demographic and medical factors. Adjusted means of outcomes of interest for each racial/ethnic group will be reported and pairwise comparisons will be conducted when significant group differences are found. In addition, the association between proximal, intermediate, and distant factors, cancer care disruptions, and health-related quality of life will be examined with bivariate correlations. Then, a series of hierarchical multiple regression analysis will investigate the contribution of the predictors on these outcomes in two steps where variables will be sequentially added and retained: (1) participant characteristics (e.g., age and race/ethnicity); and (2) the addition of proximal, intermediate, or distant factors (step 2). The increase in total explained outcome variance (∆R 2 ) will be examined. A final model including significant predictors from hierarchical multiple regression analyses will be examined. To investigate whether the model differs by race, an interaction term of race and the identified significant predictors will be introduced. Post hoc analyses will be conducted if significant interaction effect is found. p-values < 0.05 will be considered statistically significant. Statistical analyses will be performed using SAS 9.4 [164] .

Interview recordings will be transcribed verbatim. Barriers and facilitators experienced by women who report high vs. low rates of cancer care disruption across the three groups will be assessed using a grounded theory approach [165] . The constant comparison method will be used to distinguish similarities and differences across individual transcripts. Iterative data collection and analysis will be used, such that emerging results will guide subsequent data collection and refining of analytic concepts [166] . Researcher triangulation will ensure rigor in data analysis, in which two or more researchers will independently code transcripts, and meet to discuss any discrepancies in coding until agreement is reached. Transcripts of the semi-structured interviews (n = 30) will be analyzed completing three phases of coding to identify the emerging theoretical framework. The first phase, (open coding), entails intense line-by-line coding of early data to explore the dimensions and properties of emerging concepts and key processes. Subsequently, these initial codes and concepts will be condensed and organized around a single coding category (axial coding) [165] . They will be compared until a condition of theoretical saturation is reached and no new codes are identified. Finally, information will be arranged in a diagram (selective coding) synthesizing the emerging theoretical model [165] [166] [167] . Codes will be inductively derived from the data rather than being determined a priori. Atlas.ti software (ATLAS.ti Scientific Software Development GmbH, Berlin, Germany) will be used to manage and organize qualitative data [168] .

Despite growing evidence that supports adverse consequences of COVID-19 on clinical and psychosocial outcomes of cancer patients, a limited number of studies have investigated cancer care disruption and patient-reported outcomes among racial and ethnic minoritized women diagnosed with breast cancer. Given the disproportionate burden of the disease, assessing the impact of the pandemic and associated SDoH among a tri-racial and ethnic sample is critical to inform best-practices for future models of care delivery and to improve care transitions [169] [170] [171] [172] . Specifically, these data will provide the necessary evidence to inform whether a subsequent, multilevel intervention addressing these factors is warranted to improve quality of care delivery during and after the COVID-19 pandemic.

The present work will yield information about "at risk" patients that can be used to alert healthcare professionals about patient-level factors to consider when creating plans to improve care transitions. The study will also identify ways to leverage existing social resources (i.e., family caregivers, social network members, community agencies/organizations) to help manage and support patients' outcomes.

This study will add to the cancer health disparities evidence base about the: (1) impact of COVID-19 pandemic on cancer care among non-Hispanic Black/African American and Hispanic/Latina women, relative to non-Hispanic White breast cancer survivors in the U.S., and (2) the differential influence of proximal, intermediate, and distal factors on cancer care receipt and health-related quality of life of women-and specifically vulnerable groups-undergoing treatment for breast cancer during a public health crisis. Ultimately, we seek to mitigate disparities in care and outcomes for women whose health may be disproportionately affected by the effects of the pandemic and its sequelae. Funding: This research was funded by National Cancer Institute of the National Institutes of Health, through grants P20CA221697-04S1 (to Chiara Acquati), supported by grants P20CA221697 (to Lorraine R. Reitzel) and P20CA221696 (to Lorna H. McNeill). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the sponsoring organization.

The study protocol has received ethical and governance approvals from the University of Houston, Institutional Review Board, ref. number: STUDY00002665.

Informed Consent Statement: Informed consent will be obtained from all subjects involved in the study, for both quantitative and qualitative study components. All participants are free to withdraw at any time. 

Johns Hopkins Coronavirus Resource Center. COVID-19 Map

World Health Organization. WHO Coronavirus (COVID-19) Dashboard

Disproportionate impact of COVID-19 pandemic on racial and ethnic minorities

COVID-19 disparity among racial and ethnic minorities in the US: A cross sectional analysis

Cancer care disparities during the COVID-19 pandemic: COVID-19 and cancer outcomes study

Racial disparity of Coronavirus Disease 2019 in African American communities

Analyses of risk, racial disparity, and outcomes among US patients with cancer and COVID-19 infection

Personalized risk-benefit ratio adaptation of breast cancer care at the epicenter of COVID-19 outbreak

Hospitalization and mortality among Black patients and White patients with COVID-19

Are clinicians contributing to excess African American COVID-19 deaths? Unbeknownst to them, they may be

COVID-19 exacerbating inequalities in the US

Racial health disparities and Covid-19-Caution and context

Cancer survivorship care during COVID-19-perspectives and recommendations from the MASCC Survivorship Study Group

Understanding COVID-19 risks and vulnerabilities among Black communities in America: The lethal force of syndemics

Employment Situation News Release

Revisiting public health preparedness: Incorporating social justice principles into pandemic preparedness planning for influenza

Protection of racial/ethnic minority populations during an influenza pandemic

Pandemic influenza planning in the United States from a health disparities perspective

Income and Poverty in the United States

Health Insurance Coverage in the United States

Measuring Household Experiences during the Coronavirus Pandemic

The psychological and economic toll of the COVID-19 pandemic on Latina mothers in primarily low-income essential worker families

Early evidence of the impacts of COVID-19 on minority unemployment

Inequities in employment by race, ethnicity, and sector during COVID-19

Residential segregation and racial cancer disparities: A systematic review

Residential racial segregation and mortality among Black, White, and Hispanic urban breast cancer patients in Texas

The relation of residential segregation to all-cause mortality: A study in Black and White

The impact of user fees on access to health services in Low-and Middle-Income Countries

Effective health risk communication about pandemic influenza for vulnerable populations

Reductions in 2020 US life expectancy due to COVID-19 and the disproportionate impact on the Black and Latino populations

Cancer and risk of COVID-19 through a general community survey

Case fatality rate of cancer patients with COVID-19 in a New York hospital system

Clinical impact of COVID-19 on patients with cancer (CCC19): A cohort study

Risk of COVID-19 for patients with cancer

Caring for our cancer patients in the wake of COVID-19

Cancer care delivery challenges amidst Coronavirus Disease-19 (COVID-19) outbreak: Specific precautions for cancer patients and cancer care providers to prevent spread. Asian Pac

A practical approach to the management of cancer patients during the novel Coronavirus Disease 2019 (COVID-19) pandemic: An international collaborative group

The impact of the COVID-19 pandemic on cancer patients

The impact of the COVID-19 pandemic on cancer care

Impact of the COVID-19 outbreak on the management of patients with cancer

Caring for patients with cancer in the COVID-19 era

COVID-19 More Frequent, Severe in Cancer Patients

Cancer patients in SARS-CoV-2 infection: A nationwide analysis in China

COVID-19 infection in cancer patients: Early observations and unanswered questions

Clinical characteristics of COVID-19-infected cancer patients: A retrospective case study in three hospitals within Wuhan

Patients with cancer appear more vulnerable to SARS-CoV-2: A multicenter study during the COVID-19 Outbreak

Impact of COVID-19 on cancer care: How the pandemic is delaying cancer diagnosis and treatment for American seniors

Changes in the number of US patients with newly identified cancer before and during the Coronavirus Disease 2019 (COVID-19) pandemic

Cancer Patient Management During the COVID-19 Pandemic

COVID-19 Patient Care Information

COVID-19 Resources

Centers for Disease Control and Prevention

ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer

Recommendations for prioritization, treatment, and triage of breast cancer patients during the COVID-19 pandemic. The COVID-19 pandemic breast cancer consortium

Addressing the needs of cancer survivors during the COVID-19 pandemic

COVID-19 Pandemic Ongoing Impact on the Cancer Community

Meeting the challenge of the 2019 Novel Coronavirus Disease in patients with cancer

Cancer Intervention and Surveillance Modeling Network (CISNET) Collaborators. Effect of screening and adjuvant therapy on mortality from breast cancer

Earlier adjuvant therapy is beneficial in patients with breast and colon cancer

Association of surgical delay and overall survival in patients with T2 renal masses: Implications for critical clinical decision-making during the COVID-19 pandemic

Estimating excess mortality in people with cancer and multimorbidity in the COVID-19 emergency

The impact of COVID-19 on cancer screening: Challenges and opportunities

Breast imaging, breast surgery, and cancer genetics in the age of COVID-19

Patient-reported treatment delays in breast cancer care during the COVID-19 pandemic

The COVID-19 pandemic and impact on breast cancer diagnoses: What happened in England in the first half of 2020

The COVID-19 outbreak may be associated to a reduced level of care for breast cancer. A comparative study with the Pre-COVID era in an Italian breast unit

The feasibility and safety of immediate breast reconstruction in the COVID-19 era

COVID-19 lockdown and its adverse impact on psychological health in breast cancer

COVID-19 outbreak and consequent delays in schedules of the breast clinic: Effects on patients' breast and emotional symptoms

Healthcare utilization among breast cancer patients during the COVID-19 outbreak

Perspectives of cancer patients and their health during the COVID-19 pandemic

Perspectives, knowledge, and fears of cancer patients about COVID-19

Patient-reported outcomes of patients with breast cancer during the COVID-19 outbreak in the epicenter of China: A cross-sectional survey study

Time to surgery and breast cancer survival in the United States

Race and ethnicity are associated with delays in breast cancer treatment

Diagnosis and surgical delays in African American and White women with early-stage breast cancer

Purposeful surgical delay and the coronavirus pandemic: How will Black breast cancer patients fare?

Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed Coronavirus Disease 2019-COVID-NET

Texas Department of State Health Services

Breast Cancer Facts & Figures

Health disparities across the breast cancer continuum

Breast cancer interventions serving US-based Latinas: Current approaches and directions

Quality of life among Latina breast cancer patients: A systematic review of the literature

Understanding the breast cancer experience of Latina women

Correlates of quality of life among African American and White cancer survivors

Negative psychological consequences of breast cancer among recently diagnosed ethnically diverse women

Understanding racial differences in health-related quality of life in a population-based cohort of breast cancer survivors

Disparities in breast cancer outcomes between Caucasian and African American women: A model for describing the relationship of biological and nonbiological factors

Texas Department of State Health Services

Association of insurance status and racial disparities with the detection of early-stage breast cancer

Temporal trends in breast cancer survival by race and ethnicity: A populationbased cohort study

Assessing the racial and ethnic disparities in breast cancer mortality in the United States

Disparities in breast cancer tumor characteristics, treatment, time to treatment, and survival probability among African American and White women

Non-TNBC: A five-year retrospective review of differences in mean age, family history, smoking history, and stage at diagnosis at an inner-city university program

Impact of treatment and socioeconomic status on racial disparities in survival among older women with breast cancer

Association between financial burden and adjuvant hormonal therapy adherence and persistent use for privately insured women aged 18-64 years in BCBS of Texas

The association between out-of-pocket costs and adherence to adjuvant endocrine therapy among newly diagnosed breast cancer patients

Association between out-of-pocket costs, race/ethnicity, and adjuvant endocrine therapy adherence among Medicare patients with breast cancer

Factors associated with adherence to adjuvant endocrine therapy among privately insured and newly diagnosed breast cancer patients: A quantile regression analysis

Racial/Ethnic and socioeconomic disparities in endocrine therapy adherence in breast cancer: A systematic review

Adherence to adjuvant endocrine therapy in insured Black and White breast cancer survivors: Exploring adherence measures in patient data

Improving adherence to oral cancer therapy in clinical practice

Racial disparities in chemotherapy administration for early-stage breast cancer: A systematic review and meta-analysis

Disparities in breast cancer treatment and outcomes: Biological, social, and health system determinants and opportunities for research

Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer

The value of high adherence to tamoxifen in women with breast cancer: A community-based cohort study

Racial and geographic disparities in adherence and discontinuation to adjuvant endocrine therapy in Texas Medicaid-insured patients with breast cancer

Health management of breast cancer patients outside the hospital during the outbreak of 2019 novel Coronavirus Disease

Breast radiation therapy under COVID-19 pandemic resource constraints-Approaches to defer or shorten treatment from a comprehensive cancer center in the United States

International guidelines on radiation therapy for breast cancer during the COVID-19 pandemic

Toward a conceptual framework for mixed-method evaluation designs

Achieving integration in mixed methods designs-principles and practices

Introduction: Understanding and influencing multilevel factors across the cancer care continuum

The National Institute on Minority Health and Health Disparities Research Framework

Neighborhood environments and coronary heart disease: A multilevel analysis

Approaching health disparities from a population perspective: The National Institutes of Health Centers for Population Health and Health Disparities

Toward an experimental ecology of human development

Neighborhood-Level Context and Health: Lessons from Sociology. In Neighborhoods and Health

Individuals and their ecologies: Analysing the geography of chronic illness within a multilevel modelling framework

Social capital and neighborhood mortality rates in Chicago

Social ties and health: The benefits of social integration

Neighborhood differences in social capital: A compositional artifact or a contextual construct? Health Place

Health by association? Social capital, social theory, and the political economy of public health

Stress, coping, and social support processes: Where are we? What next?

Social Capital, Social Cohesion, and Health

Higher mortality in deprived areas: Community or personal disadvantage?

Phantom of the area: Poverty-area residence and mortality in the United States

Toward Improving the quality of cancer care: Addressing the interfaces of primary and oncologyrelated subspecialty care

Achieving health equity: Closing the gaps in health care disparities, interventions, and research

Structural interventions to reduce and eliminate health disparities

Designing and assessing multilevel interventions to improve minority health and reduce health disparities

A global measure of perceived stress

Barriers to and facilitative processes of endocrine therapy adherence among women with breast cancer

You want to measure coping but your protocol's too long: Consider the brief COPE

Coping with genetic testing for breast cancer susceptibility

Relations between coping responses and optimism-pessimism in predicting anticipatory psychological distress in surgical breast cancer patients

Patients' coping profiles and partners' support provision

The combined contribution of social support and coping strategies in predicting posttraumatic growth: A longitudinal study on cancer patients

Assessing self-efficacy for coping with cancer: Development and psychometric analysis of the brief version of the Cancer Behavior Inventory (CBI-B)

Social Networks across common cancer types: The evidence, gaps, and areas of potential impact

Evaluation of three short dietary instruments to assess fruit and vegetable intake: The National Cancer Institute's food attitudes and behaviors survey

The PHQ-8 as a measure of current depression in the general population

The PHQ-9 versus the PHQ-8-Is item 9 useful for assessing suicide risk in coronary artery disease patients? Data from the Heart and Soul Study

The PHQ-9: A new depression diagnostic and severity measure

A brief measure for assessing Generalized Anxiety Disorder: The GAD-7

The MOS social support survey

The future of outcomes measurement: Item banking, tailored short-forms, and computerized adaptive assessment

New English and Spanish social health measures will facilitate evaluating health determinants

Confirmatory Factor Analysis of the Patient Reported Outcomes Measurement Information System (PROMIS) Adult Domain Framework using Item Response Theory scores

Social ties and susceptibility to the common cold

Assessing Intimacy: The Pair Inventory

Use of GIS mapping as a public health tool-from cholera to cancer

Neighborhoods and Violent Crime: A multilevel study of collective efficacy

Neighborhood problems as sources of chronic stress: Development of a measure of neighborhood problems, and associations with socioeconomic status and health

The Patient Satisfaction Questionnaire Short Form (PSQ-18)

The Group-Based Medical Mistrust Scale: Psychometric properties and association with breast cancer screening

COVID-19 Pandemic Impact on Cancer Patients and Survivors. Survey Findings Summary

Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument

Behavioral Risk Factor Surveillance System Survey Questionnaire

Department of Health and Human Services

Statistical Power Analysis for the Behavioral Sciences

Basics of Qualitative Research: Techniques and Procedures for Developing Grounded Theory

The SAGE Handbook of Grounded Theory

Qualitative Inquiry and Research Design

Social determinants of racial disparities in breast cancer mortality among Black and White Women

Lessons from COVID-19: Addressing health equity in cancer care

Addressing inequities in COVID-19 morbidity and mortality: Research and policy recommendations